Cargando…
Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
Objective To measure pharmacokinetics of hydroxyprogesterone caproate (OHPC) and its major metabolites throughout pregnancy. Study Design Thirty women were prescribed OHPC for recurrent preterm birth prevention. Three cohorts of subjects had blood drawn for 7 consecutive days at one of three times...
Autores principales: | Boggess, Kim A., Baker, Jeffrey B., Murtha, Amy P., Peaceman, Alan M., Shah, Dinesh M., Siegfried, Sylvia L., Birch, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951785/ https://www.ncbi.nlm.nih.gov/pubmed/29765789 http://dx.doi.org/10.1055/s-0038-1639331 |
Ejemplares similares
-
The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011) -
Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
por: Chollet, John L., et al.
Publicado: (2012) -
Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
por: Sibai, Baha, et al.
Publicado: (2020) -
Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004) -
Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)